Results 91 to 100 of about 169,022 (378)

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia

Human Vaccines & Immunotherapeutics, 2017
Ebola hemorrhagic fever, also known as Ebola virus disease or EVD, is one of the most dangerous viral diseases in humans and animals. In this open-label, dose-escalation clinical trial, we assessed the safety, side effects, and immunogenicity of a novel,
I. V. Dolzhikova, O. V. Zubkova, A. I. Tukhvatulin, A. S. Dzharullaeva, N. M. Tukhvatulina, D. V. Shcheblyakov, M. M. Shmarov, E. A. Tokarskaya, Y. V. Simakova, D. A. Egorova, D. N. Scherbinin, I. L. Tutykhina, A. A. Lysenko, A. V. Kostarnoy, P. G. Gancheva, T. A. Ozharovskaya, B. V. Belugin, L. V. Kolobukhina, V. B. Pantyukhov, S. I. Syromyatnikova, I. V. Shatokhina, T. V. Sizikova, I. G. Rumyantseva, A. F. Andrus, N. V. Boyarskaya, A. N. Voytyuk, V. F. Babira, S. V. Volchikhina, D. A. Kutaev, A. N. Bel'skih, K. V. Zhdanov, S. M. Zakharenko, S. V. Borisevich, D. Y. Logunov, B. S. Naroditsky, A. L. Gintsburg   +35 more
doaj   +1 more source

The nexus between post conflict societies and their capacity to respond to the ebola epidemic in Mano River Union

Journal of Health Technology Assessment in Midwifery, 2021
The Ebola crisis in the Mano River States and inadequate state responses to the outbreak heightened the challenges post conflict societies face during emergencies.
Hikimatu Tuntei-ya Mohammed, Benjamin Agordzo   +1 more
doaj   +1 more source

Ebola Optimization Search Algorithm (EOSA): A new metaheuristic algorithm based on the propagation model of Ebola virus disease [PDF]

arXiv, 2021
The Ebola virus and the disease in effect tend to randomly move individuals in the population around susceptible, infected, quarantined, hospitalized, recovered, and dead sub-population. Motivated by the effectiveness in propagating the disease through the virus, a new bio-inspired and population-based optimization algorithm is proposed.
arxiv  

The Ebola virus disease outbreak in Tonkolili district, Sierra Leone: a retrospective analysis of the Viral Haemorrhagic Fever surveillance system, July 2014–June 2015 [PDF]

, 2019
In Sierra Leone, the Ebola virus disease (EVD) outbreak occurred with substantial differences between districts with someone even not affected. To monitor the epidemic, a community event-based surveillance system was set up, collecting data into the ...
Colizzi, Vittorio, DJEUNANG DONGHO, GHYSLAINE BRUNA, Miglietta, Alessandro, Montesano, Carla, Rezza, Giovanni, Russo, Gianluca, Solimini, ANGELO GIUSEPPE, Vullo, Vincenzo   +7 more
core   +1 more source

The Economic Lives of Young Women in the Time of Ebola: Lessons from an Empowerment Program

, 2019
This paper evaluates an intervention to raise young women's economic empowerment in Sierra Leone, where women frequently experience sexual violence and face multiple economic disadvantages.
O. Bandiera, N. Buehren, Markus Goldstein, Imran Rasul, A. Smurra   +4 more
semanticscholar   +1 more source

The Ebola outbreak, 2013–2016: old lessons for new epidemics

Philosophical Transactions of the Royal Society B: Biological Sciences, 2017
Ebola virus causes a severe haemorrhagic fever in humans with high case fatality and significant epidemic potential. The 2013–2016 outbreak in West Africa was unprecedented in scale, being larger than all previous outbreaks combined, with 28 646 reported
C. Coltart, B. Lindsey, Isaac Ghinai, Anne M Johnson, D. Heymann   +4 more
semanticscholar   +1 more source

Biomimetic Recognition of SARS‐CoV‐2 Receptor‐Binding Domain N‐Glycans by an Antiviral Synthetic Receptor

ChemBioChem, Volume 26, Issue 7, April 1, 2025.
Glycan‐binding agents may be a key asset in the development of new antivirals against enveloped viruses. Using a combination of glycoengineering and mass spectrometry techniques, we present here direct evidence of biomimetic recognition of the N‐glycans exposed on the receptor‐binding domain (RBD) of the wild‐type spike protein of SARS‐CoV‐2 by a ...
Carlo Santambrogio, Mirco Toccafondi, Lorena Donnici, Elisa Pesce, Raffaele De Francesco, Renata Grifantini, Erika Ponzini, Francesco Milanesi, Marco Fragai, Cristina Nativi, Stefano Roelens, Rita Grandori, Oscar Francesconi   +12 more
wiley   +1 more source

Lessons learned from Ebola Vaccine R&D during a public health emergency

Human Vaccines & Immunotherapeutics, 2018
In spite of a complete lack of Research and Development (R&D) preparedness, the 2013–2016 West-Africa Ebola experience demonstrated that it is possible to compress R&D timelines to less than a single year, from a more usual decade or longer.
Marie-Paule Kieny
doaj   +1 more source

Quantifying the impact of early-stage contact tracing on controlling Ebola diffusion

Mathematical Biosciences and Engineering, 2018
Recent experience of the Ebola outbreak in 2014 highlighted the importance of immediate response measure to impede transmission in the early stage. To this aim, efficient and effective allocation of limited resources is crucial.
Narges Montazeri Shahtori, Tanvir Ferdousi, Caterina Scoglio, Faryad Darabi Sahneh   +3 more
doaj   +1 more source

Earning their Trust

Voices in Bioethics, 2020
Traditional medicine is the oldest form of health care delivery that has stood the test of time.[1]  According to the WHO, a traditional healer is someone recognized by their community who uses natural materials and resources to provide health care ...
Sayantanee Das
doaj   +1 more source